Conditions: Neuralgia
Keywords: Neuralgia neuropathy
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 262
Healthy volunteers: no

Brief summary:
The purpose of this study is to evaluate the safety, tolerability and continued efficacy of perampanel in patients previously enrolled in double-blind, placebo-controlled studies for Painful Diabetic Neuropathy (PDN) or Post-Herpetic Neuralgia (PHN).

Detailed description:

Arms:
arm 1: None

Interventions: intervention 1: E2007
Intervention descriptions: intervention 1: Perampanel doses will be up-titrated in 2 mg steps at minimum weekly intervals starting at 2 mg daily and up-titrated to 12 mg daily (taken orally).

Protocol document: